Senescence-associated secretory factors

There are 3 papers on senescence-associated secretory factors in aging research: 1 trial in people, 1 in animals, 1 in cells. The newest story, Oct 29, 2026: “Early drug dosing prevents pain-related behavior in mice”.

Biomarker

3 papers study it10 more mention it1 finding

1 new paper in 30 daysSee all 13 papers on senescence-associated secretory factors

  • Human trial1
  • Animals1
  • Cells1

Interventions

1

Palbociclib

upin human cells1

1 study
  1. Palbociclib increases senescence-associated secretory factors in human cells (significant; P < 0.01).

    “the mRNA expression levels of senescence-related secretory factors also increased significantly in HK-2 cells after palbociclib treatment (P < 0.01).”

    Cells5 days

    Palbociclib induces cell cycle arrest and senescence of human renal tubular epithelial cells in vitro

    Nan fang yi ke da xue xue bao = Journal of Southern Medical University

More on Palbociclib

Funding

1 grant since 2025

Japan Society for the Promotion of Science¥4.7M

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 2Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 1Oct 2026: 1Nov 2026: 05 papers in 12 months
Advanced Science

Early drug dosing prevents pain-related behavior in mice

Weekly dosing for five months also preserved spinal disc volume and bone structure in mice prone to early spine degeneration.Weekly dosing for five months also preserved spinal disc volume and bone structure in mice prone to early spine degeneration.

Mouse studyInterventions

See all 13 papers on senescence-associated secretory factors